JF
AVXL icon

Jump Financial’s Anavex Life Sciences AVXL Stock Holding History

Jump Financial’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-153,231
Closed -$1.65M – 1591
2024
Q4 		$1.65M Buy
+153,231
New +$1.18M 0.03% 576
2024
Q2 		– Sell
-59,776
Closed -$304K – 1803
2024
Q1 		$304K Sell
59,776
-1,210
-2% -$6.81K 0.01% 1447
2023
Q4 		$568K Sell
60,986
-14,406
-19% -$99.2K 0.02% 988
2023
Q3 		$494K Buy
75,392
+59,024
+361% +$470K 0.02% 1024
2023
Q2 		$133K Sell
16,368
-6,632
-29% -$56.8K ﹤0.01% 1606
2023
Q1 		$197K Sell
23,000
-40,347
-64% -$403K 0.01% 1327
2022
Q4 		$587K Sell
63,347
-9,353
-13% -$99.9K 0.03% 709
2022
Q3 		$750K Buy
72,700
+62,000
+579% +$654K 0.03% 733
2022
Q2 		$107K Sell
10,700
-8,700
-45% -$82.4K ﹤0.01% 1432
2022
Q1 		$239K Buy
+19,400
New +$239K 0.01% 1200

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Jump Financial's AVXL Position: Q1 2025 in Review

Jump Financial sold out of Anavex Life Sciences (AVXL) in Q1 2025, closing a stake of 153,231 shares — an estimated $1.65M sold.

Jump Financial first reported a position in AVXL in Q1 2022 and held it in 10 quarters. The position peaked at $1.65M in Q4 2024. 181 funds tracked by Wall St. Rank hold AVXL as of Q1 2025.

  • Jump Financial reported no remaining Anavex Life Sciences position as of Q1 2025 after selling out during the quarter.
  • Jump Financial sold 153,231 Anavex Life Sciences shares in Q1 2025, an estimated $1.65M.
  • Jump Financial first reported a position in Anavex Life Sciences in Q1 2022 and held it in 10 quarters.
  • Jump Financial's Anavex Life Sciences position peaked at $1.65M in Q4 2024.
  • 181 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2025.

Based on Jump Financial's 13F filing for Q1 2025, filed 14 May 2025.